ASENAPINE MALEATE

Search structure
Trade Names:
Synonyms:
Status: Approved (2009)
Entry Type: Small molecule
Molecule Category: UNKNOWN
UNII: CU9463U2E2

Structure
InChI Key GMDCDXMAFMEDAG-BTJKTKAUSA-N
Smile CN1CC2c3ccccc3Oc3ccc(Cl)cc3C2C1.O=C(O)/C=C\C(=O)O
InChI
InChI=1S/C17H16ClNO.C4H4O4/c1-19-9-14-12-4-2-3-5-16(12)20-17-7-6-11(18)8-13(17)15(14)10-19;5-3(6)1-2-4(7)8/h2-8,14-15H,9-10H2,1H3;1-2H,(H,5,6)(H,7,8)/b;2-1-

Physicochemical Descriptors

Property Name Value
Molecular Formula C21H20ClNO5
Molecular Weight 401.85
AlogP 4.26
Hydrogen Bond Acceptor 2.0
Hydrogen Bond Donor 0.0
Number of Rotational Bond 0.0
Polar Surface Area 12.47
Molecular species NEUTRAL
Aromatic Rings 2.0
Heavy Atoms 20.0

Pharmacology

Action Mechanism of Action Reference
ANTAGONIST Dopamine D2 receptor antagonist DailyMed
Targets EC50(nM) IC50(nM) Kd(nM) Ki(nM) Inhibition(%)
Membrane receptor Family A G protein-coupled receptor Small molecule receptor (family A GPCR) Monoamine receptor Histamine receptor
- - - 6-6 -

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Bipolar Disorder 4 D001714 ClinicalTrials
Bipolar Disorder 4 D001714 ClinicalTrials
Psychotic Disorders 3 D011618 ClinicalTrials
Psychotic Disorders 3 D011618 ClinicalTrials

Related Entries

MCS

Scaffolds

Adverse Reactions

SOC By Demographic Distribution
System Organ Classification (SOC)
Relative Frequency (%)
Nervous system disorders
20.77
Psychiatric disorders
17.14
Gastrointestinal disorders
9.97
General disorders and administration site conditions
9.67
Injury, poisoning and procedural complications
7.44
Skin and subcutaneous tissue disorders
4.66
Cardiac disorders
4.44
Respiratory, thoracic and mediastinal disorders
3.74
Investigations
3.5
Musculoskeletal and connective tissue disorders
3.35
Vascular disorders
3.27
Immune system disorders
2.71
Metabolism and nutrition disorders
2.38

Cross References

Resources Reference
ChEBI 71256
ChEMBL CHEMBL3544974
DrugBank DB06216
FDA SRS CU9463U2E2
PubChem 6917875
SureChEMBL SCHEMBL6029138
ZINC ZINC00004893
CONTENTS